In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novavax, Inc.

https://novavax.com/

Latest From Novavax, Inc.

Finance Watch: Summit Raises $500m For Shift From Anti-Infectives To Oncology

Public Company Edition: Summit initiated the big rights offering earlier this year as promised in December when it licensed Akeso’s PD-1/VEGF bispecific. Also, Teva sold $2.49bn in sustainability-linked notes to pay down debt, while MorphoSys, Novavax and others restructured and cut jobs.

Finance Watch Restructuring

Scrip Asks…What Does 2023 Hold For Biopharma? Part 7: Clinical Trial Trends

From synthetic data to real-world data, from patient engagement to patient stratification, from combination trials to master protocols and from fully decentralized through hybrid to onsite trials, the world of clinical development is undergoing major changes. Fifty executives share their predictions around clinical trial trends for the year ahead.

Scrip Asks Clinical Trials

Korea's New Fast Track Scheme A GIFT For High-Need Drugs

South Korea designates two more global innovative products for support under a new fast track system, in a move set to speed up patient access to novel therapies.

South Korea Review Pathway

COVID-19 Vaccine Strain Updates Don’t Exactly Fit Flu Model

Manufacturers have different production timelines and US FDA advisory committee members worry a June strain selection may not fit the timing of COVID-19 case surges.

Coronavirus COVID-19 Vaccines
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
    • Specialty Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Liposomes
  • Other Names / Subsidiaries
    • CPL Biologicals Pvt. Ltd. (Joint Venture with Cadila)
    • Isconova AB
    • Novavax AB
UsernamePublicRestriction

Register